KRUSE BO (EVP, CFO, Secy & Treas.) sold 1.6% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $144.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/23/2021ACC: 0001104659-21-084646
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$144.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$36.17
Trade value
$144.68K
% of position
1.6%
6/22/2021
249.08K→245.08K
Total
Net shares
−4K
Net value
-$144.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2021 | S · Sale | −4K | $36.17 | $144.68K | 1.6% | 249.08K | 245.08K |
| Total | −4K | -$144.68K | ||||||
Derivative Transactions0
No derivative transactions reported